Hongkang Zhang, Ph.D.

In his role as Senior Director, Pain Therapeutics Lead at Quiver Bioscience, Hongkang Zhang manages a team of scientists and researchers to develop non-opioid therapeutics, including small molecules and antisense oligonucleotides, for chronic pain treatment. He has over 15 years of experience in leading research projects in the academic and biotech industry sectors, studying channelopathy related disorders including pain, epilepsy and cardiac arrhythmias. Hongkang received a B.S. in Biology from Peking University and a Ph.D. in Neuroscience from Johns Hopkins University. He finished his postdoctoral training in the Chemistry Department of Harvard University.